Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Lamivudine as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma (LAM-RFA)
This study is currently recruiting participants.
Study NCT00555334.   Last updated on November 17, 2008.
Information provided by Sun Yat-sen University
Please refer to this study by its ClinicalTrials.gov identifier: NCT00555334
Contacts
Contact: Min-Shan Chen, Docter 86-20-87343117 ext 86-20-87343117 Chminsh@mail.sysu.edu.cn

Locations
China, Guangdong
Department of Hepatobilliary Surgery, Cancer Center, Sun Yat-sen University Recruiting
Guangzhou, Guangdong, China, 510060
Contact: min-shan chen, doctor     86-20-87343117 ext 86-20-87343117     Chminsh@mail.sysu.edu.cn    
Sponsors and Collaborators
Sun Yat-sen University
Investigators
Principal Investigator: min-shan chen, doctor Department of Hepatobilliary Surgery, Cancer Center, Sun Yat-sen University




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services